Literature DB >> 1792557

Observer bias in the assessment of anxiety and depression.

G Lewis1.   

Abstract

Two studies are described here. In the first, an attempt is made to examine the relationship between the complaints of anxiety and depression using the results of a survey of a dermatology clinic. The Hospital Anxiety and Depression scale (HAD) and Clinical Interview Schedule (CIS) were both used in 117 unselected clinic attenders. The results showed that the self-report scales (HAD and first section of CIS) showed a closer relationship between anxiety and depression than the second section of the CIS that requires clinical judgement. In the second study, an attempt was made to distinguish between two possible explanations for this phenomenon; that psychiatrists use the constructs of anxiety and depression more carefully than patients, or alternatively that psychiatrists show an observer bias. A sample of psychiatrists were asked to complete symptom profiles for anxiety and depression; both for an imaginary 'patient' and for their own emotions, allowing psychiatrists' beliefs concerning the relationship between anxiety and depression to be studied. The results indicated that the psychiatrists thought there was a negative correlation between anxiety and depression in patients in contrast to the consistent empirical finding that anxiety and depression are positively correlated. Psychiatrists also thought anxiety and depression were less closely related in patients than in themselves. It is likely that psychiatric assessments of anxiety and depression requiring clinical judgement on the part of the interviewer are subject to observer bias. It is argued that self-report measures of psychiatric symptoms will provide more convincing evidence to resolve diagnostic disputes.

Entities:  

Mesh:

Year:  1991        PMID: 1792557     DOI: 10.1007/bf00789218

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  26 in total

1.  Depression and general psychopathology in university students.

Authors:  I H Gotlib
Journal:  J Abnorm Psychol       Date:  1984-02

2.  A scaled version of the General Health Questionnaire.

Authors:  D P Goldberg; V F Hillier
Journal:  Psychol Med       Date:  1979-02       Impact factor: 7.723

3.  The classification of psychiatric morbidity in attenders at a dermatology clinic.

Authors:  S C Wessely; G H Lewis
Journal:  Br J Psychiatry       Date:  1989-11       Impact factor: 9.319

4.  The development of a computerized assessment for minor psychiatric disorder.

Authors:  G Lewis; A J Pelosi; E Glover; G Wilkinson; S A Stansfeld; P Williams; M Shepherd
Journal:  Psychol Med       Date:  1988-08       Impact factor: 7.723

5.  The relationship between anxiety and depression. A review of some principal component analytic studies.

Authors:  J A Mullaney
Journal:  J Affect Disord       Date:  1984-10       Impact factor: 4.839

6.  The hospital anxiety and depression scale.

Authors:  A S Zigmond; R P Snaith
Journal:  Acta Psychiatr Scand       Date:  1983-06       Impact factor: 6.392

7.  Psychiatric disorder in women from an Edinburgh community: associations with demographic factors.

Authors:  P G Surtees; C Dean; J G Ingham; N B Kreitman; P M Miller; S P Sashidharan
Journal:  Br J Psychiatry       Date:  1983-03       Impact factor: 9.319

8.  A validation study of three anxiety and depression self-assessment scales.

Authors:  P R Aylard; J H Gooding; P J McKenna; R P Snaith
Journal:  J Psychosom Res       Date:  1987       Impact factor: 3.006

9.  Neurotic illness and its response to anxiolytic and antidepressant treatment.

Authors:  E C Johnstone; D G Owens; C D Frith; K McPherson; C Dowie; G Riley; A Gold
Journal:  Psychol Med       Date:  1980-05       Impact factor: 7.723

10.  Replication Of Symptom Distress Factors In Anxious Neurotic Outpatients.

Authors:  H V Williams; R S Lipman; K Rickels; L Covi; E H Uhlenhuth; N B Mattsson
Journal:  Multivariate Behav Res       Date:  1968-04-01       Impact factor: 5.923

View more
  5 in total

1.  Material standard of living, social class, and the prevalence of the common mental disorders in Great Britain.

Authors:  S Weich; G Lewis
Journal:  J Epidemiol Community Health       Date:  1998-01       Impact factor: 3.710

2.  The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomised trial.

Authors:  Gemma Lewis; Larisa Duffy; Anthony Ades; Rebekah Amos; Ricardo Araya; Sally Brabyn; Katherine S Button; Rachel Churchill; Catherine Derrick; Christopher Dowrick; Simon Gilbody; Christopher Fawsitt; William Hollingworth; Vivien Jones; Tony Kendrick; David Kessler; Daphne Kounali; Naila Khan; Paul Lanham; Jodi Pervin; Tim J Peters; Derek Riozzie; George Salaminios; Laura Thomas; Nicky J Welton; Nicola Wiles; Rebecca Woodhouse; Glyn Lewis
Journal:  Lancet Psychiatry       Date:  2019-09-19       Impact factor: 27.083

3.  A Machine Learning Approach for Continuous Mining of Nonidentifiable Smartphone Data to Create a Novel Digital Biomarker Detecting Generalized Anxiety Disorder: Prospective Cohort Study.

Authors:  Soumya Choudhary; Nikita Thomas; Sultan Alshamrani; Girish Srinivasan; Janine Ellenberger; Usman Nawaz; Roy Cohen
Journal:  JMIR Med Inform       Date:  2022-08-30

4.  Profile of the Change in Depression during Proton-Pump Inhibitor Therapy in Patients with Gastroesophageal Reflux Disease: Influence of the Mucosal Break.

Authors:  Chia-Liang Wu; Chien-Lin Chen; Shu-Hui Wen
Journal:  Int J Environ Res Public Health       Date:  2021-06-02       Impact factor: 3.390

5.  Hospital Anxiety and Depression Scale (HADS): validation in a Greek general hospital sample.

Authors:  Ioannis Michopoulos; Athanasios Douzenis; Christina Kalkavoura; Christos Christodoulou; Panayiota Michalopoulou; Georgia Kalemi; Katerina Fineti; Paulos Patapis; Konstantinos Protopapas; Lefteris Lykouras
Journal:  Ann Gen Psychiatry       Date:  2008-03-06       Impact factor: 3.455

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.